NPPB and heart failure: This finding does not support the previous research by Fellahi et al on the prognostic utility of BNP in predicting major adverse cardiac events (MACEs), that apart from heart failure included malignant ventricular arrhythmias, Q-wave infarction, and repeat revascularization, during the first 12 months following CABG or AVR.